Legend Biotech’s Post

Marc Buyse and Sébastien Coppe, PhD are at American Society of Clinical Oncology (ASCO) 2024 starting today! Reach out to them to learn how One2Treat can optimize your trial design by incorporating multiple patient-relevant outcomes into a single primary endpoint, thereby reducing your sample size.🤗 If you’re also attending #ASCO, don’t miss our #lunch events on Saturday and Sunday. Register using the link in the first comment. 👌 #ASCO2024 #ClinicalTrialDesign #PatientCentricity #ReducedSampleSize

🔔 If you are attending #ASCO24 please be sure to meet with our founder Marc Buyse, our Medical Director Everardo Saad, and the CEO of One2Treat Sébastien Coppe, PhD at our Lunch events on Saturday and Sunday! Register Here: https://lnkd.in/esSc9eHX #IDDI #ASCO24 #oncology #clinicaltrials #clinicaloncology #clinicaltrialoptimization #personalizedmedicine #regulatorystatistics #trialdesign

It is tradinionall meeting in Montenegro which was organized in Budva, April 2024. Discussion was comperhensive and fruitfull about challanging cases and improve of mCRC, H&N and UC patients treatment. Multidisciplinary team have been discussing how can together make change and paradigm shift in the treatment of oncology patients in Montenegro. #closethecaregap#innovation#access#treatmentoutcomes#

“Getting to what the patient cares about, is how you choose their treatment”, emphasized by Dr. Abraham Vergese, MD, MACP at American Society of Clinical Oncology (ASCO) 2024. This principle resonates deeply with our work at Magnolia Innovation. By integrating patient and HCP perspectives, we equip our clients with the insights needed to craft personalized strategies that truly cater to the most vulnerable patients. #asco2024 #magnoliainnovation #patientsfirst #mkg #medicalknowledgegroup #strategy #marketresearch #strategy #consulting #physicianconsultants

#HER2DX and its impact on therapeutic #decisionmaking   Understanding its credibility, and clinical relevance is crucial for optimizing treatment strategies and enhancing patient outcomes in the context of #HER2+ #breastcancer in Clinical and Translational Oncology Read it here 👉🏻https://ow.ly/YbVo50RnSp6

Hey LinkedIn! For those of you who are new to following me, I'm passionate about discussing innovation, advanced therapies, clinical trials, oncology research, and artificial intelligence in healthcare. Let' discuss how all these topics are coming together to shape present and future of Oncology Research #oncologyresearch #healthcare #innovation

An insightful read on optimizing oncology test stewardship for precision care! This article delves into the crucial intersection of technology and healthcare, highlighting the imperative role of data-driven strategies in advancing precision medicine. A must-read for anyone passionate about leveraging innovation to enhance patient outcomes in oncology - https://lnkd.in/dteRAtKe #PrecisionMedicine #HealthcareInnovation #OncologyCare #VivicaLIMS #LifeDataLab https://about.vivica.us https://lifedl.net

This article highlights the importance of judiciously utilizing oncology tests to ensure they are effectively contributing to patient care and treatment decisions. The emphasis on integrating clinical guidelines, expert consultation, and advanced technologies to streamline test utilization resonates deeply with our commitment to delivering high-quality, patient-centered care. By fostering collaboration between healthcare providers, laboratory professionals, and stakeholders, we can maximize the value of oncology testing while minimizing unnecessary testing and associated costs. Furthermore, the article's focus on leveraging data analytics and decision support tools aligns perfectly with our efforts to harness the power of data-driven insights in optimizing laboratory operations and enhancing patient outcomes. By harnessing these tools, we can better identify opportunities for improvement, tailor treatment plans to individual patient needs, and ultimately contribute to the advancement of precision medicine in oncology.

Disparities in gynecologic oncology trials: A recent study exposes racial and ethnic gaps in enrollment. Survival rates improve with trial participation, emphasizing the need for inclusive research. #ClinicalTrials #HealthEquity https://lnkd.in/ezwZvrJ5

Some patients with #prostatecancer may want to be involved in forming their survivorship care plan and recording their treatment progress. This downloadable care summary and survivorship plan template by American Society of Clinical Oncology (ASCO) can help your patients feel empowered and prepared. https://ow.ly/XLmu50PLGuT #cdc #dcpc #cctprostate #cancersurvivor #CancerIowa